Raising Awareness of PF Cough

Respivant Sciences

Respivant Sciences is developing treatments for pulmonary fibrosis (PF). A key feature of this disease in the debilitating cough that results in poor physical and mental health, and it’s believed to cause disease progression. To help raise awareness of PF Cough and Respivant’s SCENIC clinical trial, we designed patient-friendly materials for those seeking additional resources and information.


Patient Advocacy Materials

Between coordinating multiple patient awareness videos to developing informative infographics, we helped ensure the public was awareness of the devastation that PF Cough can cause in the pulmonary fibrosis community.

Social Media

We captured our many activities on Respivant’s multiple social media channels – engaging with key opinion leaders, patients and advocates – all while helping tell Respivant’s story to a broad audience.

Canale Communications ©2021